Friday, November 6, 2026
HomeHealthPreclinical research at BYU may lead to development of low-cost immunotherapy

Preclinical research at BYU may lead to development of low-cost immunotherapy

Researchers at BYU are investigating a new immunotechnology called MOTO-CAR, which can genetically engineer immune cells that penetrate solid tumors and attacks the tumor cells.

Read the full story at KSL News »

info@sportsmedical.news

RELATED ARTICLES
- Advertisment -

Most Popular

Recent Comments

Translate »